Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Bradmer announces Dr. Phil Gold to join Board of Directors
August 31st, 2007
Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, announced that Phil Gold, C.C., O.Q., M.D., Ph.D., has agreed to join the Company's Board of Directors effective immediately. Dr. Gold is a pioneer in the study of oncology and physiology with over 40 years of experience in clinical and academic settings. His early research led to the discovery and definition of the Carcinoembryonic Antigen (CEA), the blood test most frequently used in the diagnosis and management of patients with cancer. "Dr. Gold's extensive experience in the study and management of cancer will be of great benefit to our...
Source: Drug Week (2007-08-31)
|
